REG - Sunplus Technology - 1st Quarter Results

Sunplus Technology CoAnnouncement

14/05/2020 11:30

RNS Number : 9283M
  
Sunplus Technology Co Limited
  
14 May 2020
  
 

Sunplus Technology Company Limited
Consolidated Balance Sheets
Ended March 31, 2020*
(In Thousands of New Taiwan Dollars)
 



Assets


Amount


Liabilities & Shareholders Equity


Amount




Cash & Equivalent


2,751,965


Current Liabilities


1,140,035




Financial assets at fair value through profit or loss-current  


987,783


Non-Current Liabilities


573,249




Accounts & Notes receivable


752,414


Total Liabilities


1,713,284




Other Receivable


38,280


Equity attributable to owners of the parent








Inventories


919,797


Capital stock


5,919,949




Other current assets


210,650


Shares to be issued 








Total Current Assets


5,660,889


Capital surplus


599,862












Appropriated as legal reserve


1,942,388




Financial assets at fair value through profit or loss - non-current


1,028,241


Appropriated as special reserve


308,452




Financial assets at fair value through other comprehensive income - non-current


154,221


Unappropriated earnings (deficit)


(386,898)




Investments accounted for using the equity method


690,537


Others


(317,591)




Property, plant and equipment


1,981,737


Treasury Stock


(63,401)




Right-of-use asset


238,284


Total equity attributable to owners of the parent


8,002,761




Investment properties


1,036,809












Intangible Assets-Net


165,533


Non-Controlling Interests


1,422,201




Deferred tax assets


28,245


Total Shareholders¡¦ Equity


9,424,962




Net defined benefit asset, non-current


1,163












Other Non-Current Assets


152,587












Total Non-Current Assets


5,477,357












Total Assets


        11,138,246


Total Liabilities & Shareholders' Equity


11,138,246







 
Sunplus Technology Company Limited
Consolidated Statements of Income
From January 1 to March 31, 2020 and 2019
(In Thousands of New Taiwan Dollars, Except Earnings per share) 



Unit: NT$K, Except EPS


2020


2019


YoY




Net sales


1,042,456


1,179,600


(11.63)




Cost


553,934


675,023


(17.94)




Gross Profit


488,522


504,577


(3.18)




  Marketing Expense


63,864


67,375


(5.21)




  General& Administrative Expense


109,604


123,309


(11.11)




R&D Expenses


363,100


357,494


1.57




Expected credit loss


3


-


-




Other operating income(Expense)


(117)


43


(372.09)




Total operating income (expense)


(48,166)


(43,558)


10.58




Total non-operating income (expense)


(43,633)


79,891


(154.62)




Income(loss) before income tax from continued operating units


(91,799)


36,333


(352.66)




Income tax expense


13,955


7,984


74.79




Consolidated Net Income(loss)


(105,754)


28,349


(473.04)




Consolidated Net Income(loss)

Attributable To Shareholders of the parent


(124,637)


7,103


(1854.71)




Consolidated Earnings Per Share NT$ Attributable To Shareholders of the parent*


(0.21)


0.01







* Based on outstanding 588,434,923 shares on 2020/03/31




Sunplus Technology Company Limited
Consolidated Cash Flow Summary
From January 1 to March 31, 2020 and 2019
(In Thousand New Taiwan Dollars)
 



ITEM


2020


2019




Cash Flow in (out) from operating


(182,385)


29,715




Cash Flow in (out) from Investing


(24,021)


(16,275)




Cash Flow in (out) from Financing


(63,005)


(155,413)




Impact from Fx Change


748


1,013




Net Increase (Decrease) in Cash & Cash Equivalents


(268,663)


(140,960)




Cash & Cash Equivalents, Beginning of Period


3,020,628


3,235,721




Cash & Cash Equivalents, End of Period


2,751,965


3,094,761



 
 




Spokesman
Wayne Shen
Tel: +886-3-5786005 ext. 2350
E-mail: wayne@sunplus.com
 


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
QRFZZGMKGDVGGZM